Caring for people receiving belantamab mafodotin in multiple myeloma: a practical nursing guide

Podcast: Nursing Excellence in Cancer Care - Cancer Nurses Society of Australia Podcast · Cancer Nurses Society of Australia

Opublikowano: 2026-11-02

Belantamab mafodotin is now TGA-registered for people with multiple myeloma who have had at least one prior line of therapy. In this episode, nurse practitioners Trish Joyce from Peter MacCallum Cancer Centre, talks with Daniela Klarica from the Alfred Hospital in Melbourne and Sophie Wilson myeloma nurse consultant at the Royal Adelaide Hospital and the Queen Elizabeth Hospital in central Adelaide, about what nurses need to know. They cover how this antibody drug conjugate works, how to recognise and explain eye toxicity, and how eye assessments are coordinated. They also discuss infusion reactions, blood counts, infection risk, and practical patient...